Services-Commercial Physical & Biological Research · CIK 1672688
Absci Corp uses AI to design and develop antibody therapeutics for unmet medical needs
Comparable business profile · signals at a glance
In the 90 days to Mar 12, 2026: 2 insiders bought $435K · 2 sold $132K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 12, 2026 | Busch AndreasChief Innovation Officer | Buy | 100,000 | $2.29 | $229K |
| Feb 27, 2026 | Pangalos Menelas NDirector | Buy | 75,095 | $2.74 | $206K |
| Feb 2, 2026 | Mcclain SeanChief Executive Officer | Sell | 26,761 | $2.99 | $80K |
| Feb 2, 2026 | Jonasson ZachariahCFO / CBO | Sell | 17,496 | $2.99 | $52K |
| Dec 5, 2025 | Van Houten FransDirector | Buy | 40,000 | $3.72 | $149K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.